Biological Sciences Division
Published April 3, 2003 | Version v1
Patent Open

Use of methylnaltrexone and related compounds

Creators

  • 1. University of Chicago

Contributors

Patent applicant:

Description

A method for preventing or treating opioid induced side effects including changes in gastrointestinal motility. The method comprises administering methylnaltrexone or another quaternary derivative of noroxymorphone to a patient prior to the administration of an opioid or after the onset of side effects induced by the administration of an opioid, wherein the methylnaltrexone or quaternary derivative is administered orally in an enterically coated form.

Files

US20030065003.pdf

Files (378.8 kB)

Name Size Download all
md5:0048aca9b93a686f6c13b5c759b49eba
378.8 kB Preview Download

Additional details

Identifiers

Patent application number
US 27863002 A
Patent number
US 2003/0065003 A1
Other
oai:uchicago.tind.io:8703

Dates

Patent filed
2002-10-23

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Anesthesia and Critical Care